These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective. Zheng W; Guo J; Liu ZS Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic modifications in the pathogenesis of diabetic nephropathy. Reddy MA; Tak Park J; Natarajan R Semin Nephrol; 2013 Jul; 33(4):341-53. PubMed ID: 24011576 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic Risk Profile of Diabetic Kidney Disease in High-Risk Populations. Xu L; Natarajan R; Chen Z Curr Diab Rep; 2019 Feb; 19(3):9. PubMed ID: 30730019 [TBL] [Abstract][Full Text] [Related]
8. Glycemic exposure, glycemic control, and metabolic karma in diabetic complications. Thomas MC Adv Chronic Kidney Dis; 2014 May; 21(3):311-7. PubMed ID: 24780460 [TBL] [Abstract][Full Text] [Related]
9. Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice. Reddy MA; Sumanth P; Lanting L; Yuan H; Wang M; Mar D; Alpers CE; Bomsztyk K; Natarajan R Kidney Int; 2014 Feb; 85(2):362-73. PubMed ID: 24088954 [TBL] [Abstract][Full Text] [Related]
11. The role of epigenetics in the pathology of diabetic complications. Villeneuve LM; Natarajan R Am J Physiol Renal Physiol; 2010 Jul; 299(1):F14-25. PubMed ID: 20462972 [TBL] [Abstract][Full Text] [Related]
12. Epigenetics: mechanisms and implications for diabetic complications. Cooper ME; El-Osta A Circ Res; 2010 Dec; 107(12):1403-13. PubMed ID: 21148447 [TBL] [Abstract][Full Text] [Related]